Oncologists from Pittsburgh’s two giant health care networks have joined a national, five-year initiative designed to improve cancer treatment while tamping down the high cost of care.

Doctors at Allegheny Health Network and UPMC are among nearly 200 physician groups and 17 payers nationwide participating in the new Medicare program, which will offer financial incentives for meeting quality care metrics. While only people with Medicare fee-for-service coverage will be affected now, the tool will eventually become a Medicare staple, according to Virginia Calega, vice president of strategic clinical services at AHN parent Highmark.

“This is what we’re going to see in the industry,” Dr. Calega said. “We’re going to move away from fee-for-service.”

More than 1.6 million people are diagnosed with cancer each year at a cost that’s expected to reach $175 billion by 2020. The new oncology care model is designed to enhance care while slowing rising costs.

Advertise with us

The new Medicare program will reward doctors who follow nationally recognized guidelines for episodes of care that begin with chemotherapy. At AHN, patients will see lower treatment co-payments as the system anticipates trimming between 2 percent to 5 percent in overall costs over five years, according to David Parda, who heads AHN’s Cancer Institute.

“The cost of chemotherapy is exploding,” with cancer drug prices increasing by 18 percent annually, Dr. Parda said. “It’s all about integrating cancer treatment delivery and financing.”

Medicare’s new oncology care model, which begins Friday, is part of President Barack Obama’s cancer “moonshot” announced in January. Speaking Wednesday at Howard University in Washington, D.C., Vice President Joe Biden called for more affordable cancer treatments, accountability in research and better collaboration to foster more effective cancer care.

Mr. Biden’s son, Joseph R. “Beau” Biden III, died last year from brain cancer. The moonshot campaign calls for a decade’s worth of progress toward a cancer cure to be compressed into five years.

To aid that push, some 270 regional summits took shape across the country Wednesday, mirroring the Washington event, with local discussions about how to combat the disease. The University of Pittsburgh Cancer Institute in Shadyside hosted one, a four-hour long gathering that included Pitt researchers, local residents and advocacy groups.

Advertise with us

Regional organizers planned to send ideas from the forums to the Bethesda, Md.-based National Cancer Institute, where a White House task force is collaborating with a blue-ribbon panel.

“We need to open the dialogues between patients and physicians for better outcomes, as well as implement services and support to improve the quality of life for patients and families,” said Marina Posvar, a two-time breast cancer survivor and patient navigator at UPMC CancerCenter.

AHN’s involvement in the Medicare program will include opening an extended-hours oncology urgent care center at West Penn Hospital in Bloomfield. The center, scheduled to open in the coming months, is expected to reduce cancer treatment costs by helping patients avoid trips to the hospital emergency room.

Dr. Parda estimated Medicare fee-for-service members at 5 to 10 percent of AHN’s total number of cancer patients. An exact number was not available, but Medicare managed care coverage dominates health insurance for seniors in Allegheny County.

The new Medicare reimbursement program is the latest development in the federal government’s push to pay for value of care provided rather than number of procedures performed. Clinical quality of care, communication, outcomes and other metrics will be used to determine performance-based payments.

Advertise with us

AHN and UPMC will be eligible for a monthly bonus of $160 per Medicare member plus a performance-based payment for each episode of care for meeting the quality metrics. Nearly every kind of cancer is covered by the new program.

In a related matter announced Wednesday, cancer genomic profile information from an additional 18,000 adult cancer patients will be added to the Genomic Data Commons, nearly doubling the size of the existing database. Foundation Medicine Inc., a molecular information company based in Cambridge, Mass., which creates genomic profiles of people with cancer, operates the database in cooperation with the government’s National Cancer Institute.

Adam Smeltz contributed.